Analystreport

CTI BioPharma Corp (NASDAQ: CTIC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

CTI BioPharma Corp.  (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com